These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 31362457)
21. Levels of 17β-Hydroxysteroid Dehydrogenase Type 10 in Cerebrospinal Fluid of People with Mild Cognitive Impairment and Various Types of Dementias. Kristofikova Z; Ricny J; Vyhnalek M; Hort J; Laczo J; Sirova J; Klaschka J; Ripova D J Alzheimers Dis; 2015; 48(1):105-14. PubMed ID: 26401932 [TBL] [Abstract][Full Text] [Related]
22. Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics. Kissinger CR; Rejto PA; Pelletier LA; Thomson JA; Showalter RE; Abreo MA; Agree CS; Margosiak S; Meng JJ; Aust RM; Vanderpool D; Li B; Tempczyk-Russell A; Villafranca JE J Mol Biol; 2004 Sep; 342(3):943-52. PubMed ID: 15342248 [TBL] [Abstract][Full Text] [Related]
23. Identification of small-molecule inhibitors of the Abeta-ABAD interaction. Xie Y; Deng S; Chen Z; Yan S; Landry DW Bioorg Med Chem Lett; 2006 Sep; 16(17):4657-60. PubMed ID: 16781151 [TBL] [Abstract][Full Text] [Related]
24. Physiologically relevant fluorescent assay for identification of 17β-hydroxysteroid dehydrogenase type 10 inhibitors. Schmidt M; Vaskova M; Rotterova A; Fiandova P; Miskerikova M; Zemanova L; Benek O; Musilek K J Neurochem; 2023 Oct; 167(2):154-167. PubMed ID: 37458164 [TBL] [Abstract][Full Text] [Related]
25. Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase. Yang SY; He XY; Schulz H Trends Endocrinol Metab; 2005; 16(4):167-75. PubMed ID: 15860413 [TBL] [Abstract][Full Text] [Related]
26. (-)-CHANA, a fluorogenic probe for detecting amyloid binding alcohol dehydrogenase HSD10 activity in living cells. Muirhead KE; Froemming M; Li X; Musilek K; Conway SJ; Sames D; Gunn-Moore FJ ACS Chem Biol; 2010 Dec; 5(12):1105-14. PubMed ID: 20836522 [TBL] [Abstract][Full Text] [Related]
28. Hydroxysteroid (17β) dehydrogenase X in human health and disease. Yang SY; He XY; Miller D Mol Cell Endocrinol; 2011 Aug; 343(1-2):1-6. PubMed ID: 21708223 [TBL] [Abstract][Full Text] [Related]
29. Friend or enemy? Review of 17β-HSD10 and its role in human health or disease. Vinklarova L; Schmidt M; Benek O; Kuca K; Gunn-Moore F; Musilek K J Neurochem; 2020 Nov; 155(3):231-249. PubMed ID: 32306391 [TBL] [Abstract][Full Text] [Related]
30. ABAD/17β-HSD10 reduction contributes to the protective mechanism of huperzine a on the cerebral mitochondrial function in APP/PS1 mice. Xiao X; Chen Q; Zhu X; Wang Y Neurobiol Aging; 2019 Sep; 81():77-87. PubMed ID: 31252207 [TBL] [Abstract][Full Text] [Related]
31. Levels of 17β-hydroxysteroid dehydrogenase type 10 in CSF are not a valuable biomarker for multiple sclerosis. Kristofikova Z; Ricny J; Kaping D; Klaschka J; Kotoucova J; Bartos A Biomark Med; 2018 Dec; 12(12):1331-1340. PubMed ID: 30520659 [TBL] [Abstract][Full Text] [Related]
32. Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease. Morsy A; Trippier PC J Med Chem; 2019 May; 62(9):4252-4264. PubMed ID: 30444369 [TBL] [Abstract][Full Text] [Related]
33. Harnessing functional plasticity of enzymes: a fluorogenic probe for imaging 17beta-HSD10 dehydrogenase, an enzyme involved in Alzheimer's and Parkinson's diseases. Froemming MK; Sames D J Am Chem Soc; 2007 Nov; 129(46):14518-22. PubMed ID: 17958419 [TBL] [Abstract][Full Text] [Related]
34. Undetectable levels of CSF amyloid-β peptide in a patient with 17β-hydroxysteroid dehydrogenase deficiency. Ortez C; Villar C; Fons C; Duarte ST; Pérez A; García-Villoria J; Ribes A; Ormazábal A; Casado M; Campistol J; Vilaseca MA; García-Cazorla A J Alzheimers Dis; 2011; 27(2):253-7. PubMed ID: 21841256 [TBL] [Abstract][Full Text] [Related]
35. ABAD: a potential therapeutic target for Abeta-induced mitochondrial dysfunction in Alzheimer's disease. Marques AT; Fernandes PA; Ramos MJ Mini Rev Med Chem; 2009 Jul; 9(8):1002-8. PubMed ID: 19601895 [TBL] [Abstract][Full Text] [Related]
36. Oxidative 3alpha-hydroxysteroid dehydrogenase activity of human type 10 17beta-hydroxysteroid dehydrogenase. He XY; Yang YZ; Peehl DM; Lauderdale A; Schulz H; Yang SY J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):191-8. PubMed ID: 14672739 [TBL] [Abstract][Full Text] [Related]
37. C-3 Steroidal Hemiesters as Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 10. Hanzlova M; Slavikova B; Morozovova M; Musilek K; Rotterova A; Zemanová L; Kudova E ACS Omega; 2024 Mar; 9(10):12116-12124. PubMed ID: 38496976 [TBL] [Abstract][Full Text] [Related]
38. In Vitro Assay Development and HTS of Small-Molecule Human ABAD/17β-HSD10 Inhibitors as Therapeutics in Alzheimer's Disease. Aitken L; Baillie G; Pannifer A; Morrison A; Jones PS; Smith TK; McElroy SP; Gunn-Moore FJ SLAS Discov; 2017 Jul; 22(6):676-685. PubMed ID: 28314118 [TBL] [Abstract][Full Text] [Related]
39. Intracellular oxidation of allopregnanolone by human brain type 10 17beta-hydroxysteroid dehydrogenase. He XY; Wegiel J; Yang SY Brain Res; 2005 Apr; 1040(1-2):29-35. PubMed ID: 15804423 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of 17β-hydroxysteroid dehydrogenase type 10 increases pheochromocytoma cell growth and resistance to cell death. Carlson EA; Marquez RT; Du F; Wang Y; Xu L; Yan SS BMC Cancer; 2015 Mar; 15():166. PubMed ID: 25879199 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]